深天馬A(000050.SZ):股東金財產業非公開發行可交債將於7月6日進入換股期
格隆匯7月5日丨深天馬A(000050.SZ)公佈,公司近日收到持股5%以上股東廈門金財產業發展有限公司(“金財產業”)通知,獲悉金財產業非公開發行可交換公司債券將於2021年7月6日進入換股期。
此前披露,2021年1月5日,金財產業完成非公開發行可交換公司債券,本期可交換公司債券的債券簡稱為“20金財E1”,債券代碼為“117173.SZ”,實際發行規模為15億元,債券期限為3年,票面利率為0.4%。
根據募集説明書的約定,本期可交換公司債券換股期限自本期債券發行結束之日起六個月後第一個交易日起至摘牌日前一個交易日止,即2021年7月6日至2024年1月4日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.